Griseofulvin

Common Uses

Griseofulvin is primarily used to treat infections caused by fungi that affect different parts of the body. These conditions are often referred to as tinea infections and include:

• Ringworm: Fungal infections of the body or limbs.
• Athlete's foot: Fungal infections affecting the feet and between the toes.
• Jock itch: Fungal infections in the groin area.
• Scalp infections: Fungal infections of the hair and scalp.
• Nail infections: Fungal infections involving the fingernails or toenails.
• Barber's itch: Fungal infections of the beard area.

This medication is typically reserved for infections that involve the hair or nails, or for skin infections that are widespread or have not improved with the use of antifungal creams, lotions, or ointments applied directly to the skin.

How Griseofulvin Works

Griseofulvin belongs to a group of medicines called antifungals. It is used to treat infections caused by dermatophytes, which are fungi that thrive on the keratin found in your skin, hair, and nails.

The medication works through the following process:

• Stopping fungal growth: Griseofulvin interferes with the way fungal cells divide and multiply, which prevents the infection from spreading.
• Binding to keratin: When the medication is taken, the body deposits it into the precursor cells that eventually become skin, hair, and nails. It binds tightly to the keratin in these new cells.
• Creating a barrier: This binding process makes the new tissue resistant to fungal invasion. As the fungus is unable to penetrate the new growth, the infection is contained.

Because griseofulvin works by protecting new growth, the time it takes to see results depends on how fast your skin, hair, or nails grow. The infection is cured only after the old, infected tissue has been completely replaced by the new, healthy tissue that contains the medication. This is why treatment for nail infections often takes much longer than treatment for skin infections.

It is important to note that griseofulvin is only effective against specific types of fungi. It will not work for infections caused by bacteria or other types of fungi, such as yeast.

Common Side Effects

The following side effects are more common and may go away as your body adjusts to the medication:

• Headache
• Nausea or vomiting
• Diarrhea or stomach pain
• Dizziness or tiredness
• Confusion or trouble sleeping
• White patches or sores inside the mouth

Serious Side Effects

Contact a healthcare provider immediately if you experience any of the following serious symptoms:

• Signs of an allergic reaction, such as hives, skin rash, or swelling of the face, lips, or tongue
• Severe skin reactions, including blistering, peeling, or a red skin rash
• Liver problems, indicated by yellowing of the skin or eyes (jaundice), dark urine, or pain in the upper right stomach
• Numbness, tingling, or burning pain in the hands or feet
• Joint pain or a butterfly-shaped rash on the nose and cheeks
• Fever, chills, or persistent sore throat

Sun Sensitivity

Griseofulvin may make your skin more sensitive to sunlight. It is important to wear protective clothing and use sunscreen while taking this drug to avoid severe sunburn or skin reactions.

Contraindications

Griseofulvin should not be used by individuals with the following conditions:

• Pregnancy: This medication can cause fetal harm and is contraindicated for use during pregnancy.
• Porphyria: Griseofulvin may worsen this metabolic disorder.
• Liver Disease: It is contraindicated in individuals with hepatocellular failure or severe liver impairment.

Serious Skin Reactions

Severe and potentially life-threatening skin reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis, have been reported with griseofulvin use. Treatment should be discontinued if a skin rash or mucosal lesions appear.

Liver Toxicity

Hepatotoxicity, including jaundice and elevated liver enzymes, may occur during treatment. Healthcare providers typically monitor liver function periodically, especially during long-term therapy. Individuals with pre-existing liver conditions require close supervision.

Lupus Erythematosus

Griseofulvin has been known to trigger or exacerbate systemic lupus erythematosus. Patients should be alert for new symptoms such as joint pain or skin rashes.

Photosensitivity

This medication can increase the skin's sensitivity to ultraviolet light. It is recommended to avoid prolonged exposure to direct sunlight or tanning beds and to use protective clothing or sunscreen while taking this drug.

Reproductive Precautions

Due to the potential for genetic damage to sperm or fetal harm, specific precautions are necessary:

• Women: Pregnancy must be avoided during treatment.
• Men: Men should wait at least six months after completing griseofulvin therapy before fathering a child.

Other Precautions

• Alcohol Interaction: Griseofulvin may enhance the effects of alcohol, potentially causing symptoms such as flushing, nausea, or a rapid heartbeat.
• Penicillin Sensitivity: Because griseofulvin is derived from species of Penicillium, there is a theoretical risk of cross-sensitivity in people allergic to penicillin, though this is rare.
• Laboratory Monitoring: Long-term use requires periodic assessment of organ system functions, including renal and hematopoietic (blood cell) monitoring.
• Contraception: Griseofulvin may decrease the effectiveness of oral contraceptives, increasing the risk of unintended pregnancy.

Pregnancy

Griseofulvin is generally not recommended for use during pregnancy. Studies and reports indicate that the medication may cause harm to a developing fetus or lead to birth defects. If you are pregnant or planning to become pregnant, it is important to discuss alternative treatment options with a healthcare provider.

Because the medication can remain in the body or affect reproductive cells, the following precautions are typically advised:

• For women: Use effective birth control during treatment and continue using it for at least one month after the final dose.
• For men: Use a condom and avoid fathering a child during treatment and for at least six months after stopping the medication, as griseofulvin may affect sperm cells.

Breastfeeding

It is not known whether griseofulvin passes into human breast milk or how it might affect a nursing infant. Because the safety of this medication during breastfeeding has not been established, healthcare providers usually recommend caution. Consult a medical professional to determine if the benefits of the medication outweigh the potential risks to the baby while nursing.

Available Forms

Griseofulvin is provided in two distinct formulations: microsize and ultramicrosize. It is important to note that these two types are not interchangeable because the body absorbs them differently. The ultramicrosize formulation is absorbed more efficiently, meaning a smaller dose is needed compared to the microsize version.

The medication is available in the following forms:

• Oral Suspension (Microsize): A liquid form often used for children or individuals who have difficulty swallowing tablets.
• Tablets (Microsize): Solid oral tablets.
• Tablets (Ultramicrosize): Solid oral tablets designed for enhanced absorption.

Specific strengths vary depending on the formulation and the manufacturer. Patients should always verify which version they have been prescribed to ensure the correct dosage is taken, as the milligram amounts for microsize and ultramicrosize products are not equivalent.

FDA Approval Status

Griseofulvin is approved by the U.S. Food and Drug Administration (FDA) as an oral antifungal treatment. It is available in two primary formulations: microsize and ultramicrosize. These forms are not interchangeable because they are absorbed by the body at different rates, with the ultramicrosize version being more easily absorbed.

Approved Indications

The FDA has approved griseofulvin for the treatment of fungal infections (tinea) caused by specific types of fungi, including Trichophyton, Microsporum, and Epidermophyton. Approved uses include:

• Tinea corporis (ringworm of the body)
• Tinea pedis (athlete's foot)
• Tinea cruris (jock itch)
• Tinea barbae (barber's itch)
• Tinea capitis (ringworm of the scalp)
• Tinea unguium (onychomycosis or fungal infection of the nails)

It is generally indicated for infections that have not responded to topical treatments or for infections involving the hair and nails where topical creams are less effective.

Safety and Monitoring

There are currently no boxed warnings or Risk Evaluation and Mitigation Strategies (REMS) required by the FDA for griseofulvin. However, the FDA-approved labeling includes warnings regarding potential liver toxicity and serious skin reactions. Because it may cause photosensitivity, patients are often advised to avoid intense sunlight. Periodic monitoring of organ system functions, including hepatic, renal, and hematopoietic systems, is recommended during long-term therapy.

Types of Fungal Infections Treated

Griseofulvin is primarily used to treat infections caused by a group of fungi known as dermatophytes. These infections include:

• Ringworm of the body: A red, itchy, circular rash on the skin.
• Scalp ringworm: An infection that can cause itchy, scaly patches on the scalp and may lead to temporary hair loss.
• Athlete's foot: A fungal infection that typically affects the skin between the toes.
• Jock itch: An infection in the groin or inner thigh area.
• Nail infections: Fungal growth that affects the fingernails or toenails, often causing them to become thick or brittle.

How It Works

This medication works by binding to keratin, a protein found in the skin, hair, and nails. By doing so, it prevents the fungi from infecting new tissue as it grows. Because the medication works on new growth, the infection is only fully cleared once the old, infected skin or nail has been replaced by healthy tissue. This process can take several weeks for skin infections and several months for nail infections.

Limitations

Griseofulvin is specific to certain fungal types. It is not effective against:

• Bacterial infections.
• Viral infections.
• Yeast infections, such as those caused by Candida.